ADLM 2024 BOLD MOVE.

Feasibility study of an Automated Targeted Metagenomics NGS Application for Rapid Detection of Bacteria and Fungi Directly from Specimens

Wednesday, July 31
Time: 11:30 - 11:50 a.m.
Location: Exhibit Hall Theater #2
Sponsored by Thermo Fisher Scientific

Overview

Rapid detection and identification of microbial pathogens in the laboratory is imperative. However, standard microbiology testing approaches often depend on the recovery and culture of viable organisms, limiting their utility use. More recently, next-generation sequencing (NGS) approaches have been successfully used for various applications within the laboratory, but adoption in most laboratories is unlikely challenging due to the complexity, expertise, and resources required. To address these shortcomings, we developed evaluated an automated targeted metagenomic NGS method to rapidly detect bacteria and fungi directly from specimens. This presentation will describe the performance of this new approach and its advantages over other methods.

Moderator

Kevin Bryant, PhD, Sr. Manager
Global Market Development, Thermo Fisher Scientific

Speaker

Jennifer Dien Bard, PhD, D(ABMM), FIDSA, FAAM
Professor of Pathology (Clinical Scholar), Keck School of Medicine, University of Southern California. Interim Chief of Lab Medicine and Director, Clinical Microbiology and Virology, Children's Hospital of Los Angeles